Prevalence of drug resistant gene and changes in susceptibility of methicillin-resistant Staphylococcus aureus strains isolated from 1990 to 2006 in Japan to antimicrobial agents

Japanese Journal of Chemotherapy

Volumn 57, Issue 1, 2009, Pages 37-40

  Mikuniya, Takeshi ^a   Kato, Yoshihisa ^a   Muto Kobayashi, Yuko ^a   Sanbongi, Yumiko ^a   Shimizu, Atsuyuki ^a   Hiraishi, Toru ^a   Ida, Takashi ^a   Maebashi, Kazunori ^a  

^a MEIJI SEIKA KAISHA LTD   (Japan)

Author keywords

Clinical isolate; Drug susceptibility; Methicillin resistant Staphylococcus aureus; Surveillance

Indexed keywords

AMINOGLYCOSIDE ACETYLTRANSFERASE; AMINOGLYCOSIDE PHOSPHOTRANSFERASE; ANTIBIOTIC AGENT; HABEKACIN; LINEZOLID; TEICOPLANIN; TRANSFERASE; UNCLASSIFIED DRUG; VANCOMYCIN;

AMINO ACID SUBSTITUTION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; JAPAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; TREND STUDY;

EID: 59649127661     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E: Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006; 368: 874-85
2. Japanese source.
3. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard-Seventh edition. CLSI M7-A7; 2006
4. Ida T, Okamoto R, Shimauchi C, Okubo T, Kuga A, Inoue M: Identification of aminoglycoside-modifying enzymes by susceptibility testing: Epidemiology of methicillin-resistant Staphylococcus aureus in Japan J Clin Microbiol 2001; 39: 3115-21
5. Kato Y, Suzuki T, Ida T, Maebashi K, Sakurai M, Shiotani J, et al: Microbiological and clinical study of methicillin-resistant Staphylococcus aureus (MRSA) carrying VraS mutation: changes in susceptibility to glycopeptides and clinical siginificance. Int J Antimicrob Agents 2008; 31: 64-70
6. Japanese source.
7. Tsuchizaki N, Ishino K, Saito F, Ishikawa J, Nakajima M, Hotta K: Trends of arbekacin-resistant MRSA strains in Japanese hospitals (1979 to 2000). J Antibiot 2006; 59: 229-33
8. Barada K, Hanaki H, Ikeda S, Yamaguchi Y, Akama H, Nakae T, et al: Trends in the gentamicin and arbekacin susceptibility of methicillin-resistant Staphylococcus aureus and the genes encoding aminoglycoside-modifying enzymes. J Infect Chemother 2007; 13: 74-8
9. Ishino K, Ishikawa J, Ikeda Y, Hotta K: Characterization of a bifunctional aminoglycoside-modifying enzyme with novel substrate specificity and its gene from a clinical isolate of methicillin-resistant Staphylococcus aureus with high arbekacin resistance. J Antibiot 2004; 57: 679-86